Update on acute coronary syndromes: the pathologists' view
The DOI matches its Crossref record; 160 of the 161 references it cites were found in a registry or an index.
Abstract
Although mortality rates from coronary heart disease in the western countries have declined in the last few decades, morbidity caused by this disease is increasing and a substantial number of patients still suffer acute coronary syndrome (ACS) and sudden cardiac death. Acute coronary syndrome occurs as a result of myocardial ischaemia and its manifestations include acute myocardial infarction and unstable angina. Culprit plaque morphology in these patients varies from thrombosis with or without coronary occlusion to sudden narrowing of the lumen from intraplaque haemorrhage. The coronary artery plaque morphologies primarily responsible for thrombosis are plaque rupture, and plaque erosion, with plaque rupture being the most common cause of acute myocardial infarction, especially in men. Autopsy data demonstrate that women <50 years of age more frequently have erosion, whereas in older women, the frequency of rupture increases with each decade. Ruptured plaques are associated with positive (expansive) remodelling and characterized by a large necrotic core and a thin fibrous cap that is disrupted and infiltrated by foamy macrophages. Plaque erosion lesions are often negatively remodelled with the plaque itself being rich in smooth muscle cells and proteoglycans with minimal to absence of inflammation. Plaque haemorrhage may expand the plaque rapidly, leading to the development of unstable angina. Plaque haemorrhage may occur from plaque rupture (fissure) or from neovascularization (angiogenesis). Atherosclerosis is now recognized as an inflammatory disease with macrophages and T-lymphocytes playing a dominant role. Recently at least two subtypes of macrophages have been identified. M1 is a pro-inflammatory macrophage while M2 seems to play a role in dampening inflammation and promoting tissue repair. A third type of macrophage, termed by us as haemoglobin associated macrophage or M(Hb) which is observed at site of haemorrhage also can be demonstrated in human atherosclerosis. In order to further our understanding of the specific biological events which trigger plaque instability and as well as to monitor the effects of novel anti-atherosclerotic therapies newer imaging modalities in vivo are needed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In postmenopausal women, plaque rupture was found to be a more common cause of ACS than plaque erosion and is correlated with TC levels. 313”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [313]
Citations
Cites
Inflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Roffi, M., Patrono, C., Collet, J.-P., Mueller, C., Valgimigli, M., Andreotti, F., Bax, J. J., Borger, M. A., Brotons, C., Chew, D. P., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehv320 · Cited by 8,261
Virmani, R., Kolodgie, F. D., Burke, A. P., Farb, A., & Schwartz, S. M. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.5.1262 · Cited by 4,084 · cited 13×
“Vulnerable plaques of the erosion-prone type are heterogeneous and defined only by their fate (thrombosis, mostly mural).(36) The surface endothelium is missing, but whether it vanished before or after thrombosis remains unknown.”
BackgroundMethodInfluentialSelf-citationProgress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
Falk, E., Shah, P. K., & Fuster, V. (1995) · Circulation · doi:10.1161/01.cir.92.3.657 · Cited by 3,536 · cited 2×
“The prototype of a presumed rupture-prone plaque contains a large and soft lipid-rich necrotic core covered by a thin and inflamed fibrous cap.(42,66) Associated features include big plaque size, expansive remodelling mitigating luminal obstruction (mild stenosis by angiography), neovascularization (angiogenesis), pla…”
BackgroundSelf-citationStary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,533
A Prospective Natural-History Study of Coronary Atherosclerosis
Stone, G. W., Maehara, A., Lansky, A. J., de Bruyne, B., Cristea, E., Mintz, G. S., Mehran, R., McPherson, J., Farhat, N., Marso, S. P., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1002358 · Cited by 3,276 · cited 1×
“PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) was the first and is the largest natural-history study of coronary atherosclerosis using multimodality intracoronary imaging to identify vulnerable plaques to date.(115)”
BackgroundHeidenreich, P. A., Trogdon, J. G., Khavjou, O. A., Butler, J., Dracup, K., Ezekowitz, M. D., Finkelstein, E. A., Hong, Y., Johnston, S. C., Khera, A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820a55f5 · Cited by 3,208
Cited by
Items 401–500 of 1,000
Hernández, J. L., Conde, C. B., López‐Sundh, A. E., Ocejo-Vinyals, J. G., Blanco, R., & González-López, M. A. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01377-6 · Cited by 21
Physiopathologie et étiopathogénie de l’infarctus du myocarde
Akoudad, H., Benamer, H., & Kamal, A. (2004) · EMC - Cardiologie · doi:10.1016/j.emcaa.2003.12.003 · Cited by 22
Intravascular imaging of coronary artery disease: recent progress and future directions
Ochijewicz, D., Tomaniak, M., Kołtowski, Ł., Rdzanek, A., Pietrasik, A., & Kochman, J. (2017) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000552 · Cited by 21
In vivovisualization of lipid coronary atheroma with intravascular near-infrared spectroscopy
Kataoka, Y., Puri, R., Andrews, J., Honda, S., Nishihira, K., Asaumi, Y., Noguchi, T., Yasuda, S., & Nicholls, S. J. (2017) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2017.1367287 · Cited by 21
Clinical Relevance of Histopathologic Analysis of HeartMate II Thrombi
Kreuziger, L. B., Slaughter, M. S., Sundareswaran, K. S., & Mast, A. E. (2018) · ASAIO Journal · doi:10.1097/mat.0000000000000759 · Cited by 21
González-Ramos, S., Fernández-García, V., Recalde, M., Rodríguez, C., Martínez‐González, J., Andrés, V., Martín‐Sanz, P., & Boscá, L. (2020) · Cells · doi:10.3390/cells9092067 · Cited by 21
NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice
Grootaert, M. O. J., Schrijvers, D. M., Spaendonk, H. V., Breynaert, A., Hermans, N., Hoof, V. O. V., Takahashi, N., Vandenabeele, P., Kim, S. H., Meyer, G. R. Y. D., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.06.045 · Cited by 21
Jinnouchi, H., Virmani, R., & Finn, A. V. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy113 · Cited by 21
Self-citationAbdelwahed, Y. S., Nelles, G., Frick, C., Seppelt, C., Meteva, D., Stähli, B. E., Rai, H., Riedel, M., Skurk, C., Rauch‐Kröhnert, U., et al. (2021) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jeab247 · Cited by 20
Rajakumar, H. K., Sathyabal, V. C., Vasanthan, M., & Dasarathan, R. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e39029 · Cited by 20
“Additionally, damaged atherosclerotic plaques activate platelets, potentially leading to thrombus formation and subsequent obstruction of coronary blood flow, resulting in myocardial ischemia [25].”
Molecular Imaging of Angiogenesis and Vascular Remodeling in Cardiovascular Pathology
Golestani, R., Jung, J., & Sadeghi, M. M. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5060057 · Cited by 20
“In parallel, angiogenesis plays a deleterious role in atherosclerosis as the presence of extensive neovessels (and intra-plaque hemorrhage) is linked to atherosclerotic plaque vulnerability [10].”
BackgroundSun, J., Xiang, Q., Li, C., Wang, Z., Hu, K., Xie, Q., & Cui, Y. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000459 · Cited by 20
Khoury, S., Soleman, M., Margolis, G., Barashi, R., Rozenbaum, Z., Keren, G., & Shacham, Y. (2019) · Coronary Artery Disease · doi:10.1097/mca.0000000000000779 · Cited by 20
Hu, P., Huang, M., Hu, X., Xie, X.-J., Xiang, M., Liu, X., & Wang, J.-A. (2015) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1400241 · Cited by 20
Kogo, T., Hiro, T., Kitano, D., Takayama, T., Fukamachi, D., Morikawa, T., Sudo, M., & Okumura, Y. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01110-8 · Cited by 20
Investigation of Specific Proteins Related to Different Types of Coronary Atherosclerosis
Meng, H., Ruan, J., Chen, Y., Yan, Z., Shi, K., Li, X., Yang, P. C., & Meng, F. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.758035 · Cited by 20
“These exclusion criteria were as follows: (1) myocardial infarction associated with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG); (2) type I myocardial infarction, namely secondary myocardial infarction, associated with blood supply imbalance or myocardial infarction caused by ele…”
BackgroundMethodCoronary Artery Disease: Pathological Anatomy and Pathogenesis
Buja, L. M. (2015) · Cardiovascular medicine · doi:10.1007/978-1-4471-2828-1_1 · Cited by 20
Sun, H., Zhao, C., Qin, Y., Li, C., Jia, H., Yu, B., & Wang, Z. (2022) · Biomedical Optics Express · doi:10.1364/boe.459623 · Cited by 20
Li, X., Che, L., Wang, W., Liu, L., & Ning, Z. (2022) · Biochemia Medica · doi:10.11613/bm.2023.010702 · Cited by 20
Nappi, F., Bellomo, F., & Singh, S. S. A. (2023) · Biomedicines · doi:10.3390/biomedicines11010113 · Cited by 20
Puddu, P. E., Terradura-Vagnarelli, O., Mancini, M., Zanchetti, A., & Menotti, A. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.021 · Cited by 20
“The T-CHD deaths may have a more clearcut definition, at least from the morphological point of view [4,5,8,9]; however, the differentiation may still be difficult pre-mortem, to the extent that the clinical definitions for these events, either fatal or not, have still some areas of uncertainty notwithstanding the adva…”
BackgroundResultComentarios al consenso ESC 2018 sobre la cuarta definición universal del infarto de miocardio
Sambola, A., Viana‐Tejedor, A., Bueno, H., Barrabés, J. A., Delgado, V., Jiménez, P., Pérez, P. J., Noriega, F. J., Vila-Perales, M., Aboal, J., et al. (2018) · Revista Española de Cardiología · doi:10.1016/j.recesp.2018.11.009 · Cited by 20
Usman, A., Patterson, A. J., Yuan, J., Cluroe, A. D., Patterson, I., Graves, M. J., Gillard, J. H., & Sadat, U. (2020) · Scientific Reports · doi:10.1038/s41598-020-58708-x · Cited by 20
Du, G., Liu, F., Liu, H., Meng, Q., Tang, R., Li, X., Yang, Y., & Gao, X.-M. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s419579 · Cited by 19
Vázquez, G., Solanki, S. A., Dube, P., Smedlund, K., & Ampem, P. T. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-26974-0_9 · Cited by 19
Genome-wide DNA methylome alterations in acute coronary syndrome
Li, D., Yan, J., Yuan, Y., Wang, C., Wu, J., Chen, Q., Song, J., & Wang, J. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3220 · Cited by 19
“Acute coronary syndrome (ACS) is a type of cardiovascular disease (CVD) that occurs as a result of an acute obstruction in the coronary arteries, and it represents a leading cause of mortality and disability worldwide (1-3).”
Lu, W., Park, S., Meng, Z., Wang, F., & Zhou, C. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012009 · Cited by 19
“In addition to contributing to atherosclerotic lesion growth, inflammation may affect atherosclerotic plaque stability, plaque rupture, and thrombosis.(5,6,8,9,56) Accumulating evidence indicates that the major atherosclerosis complication is the rupture of atherosclerotic plaque,(57) and stabilizing plaque”
Kay, F. U., Canan, A., & Abbara, S. (2019) · Korean Circulation Journal · doi:10.4070/kcj.2019.0315 · Cited by 19
Meng, Z., Hernandez, R., Liu, J., Gwag, T., Lu, W., Hsiai, T. K., Kaul, M., Zhou, T., & Zhou, C. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07141-x · Cited by 19
Yao, Y., Li, X., Wang, Z., Ji, Q., Xu, Q., Yan, Y., & Lv, Q. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.753171 · Cited by 19
PET Imaging of Atherosclerosis
Tarkin, J. M., Joshi, F. R., Rajani, N. K., & Rudd, J. H. F. (2015) · Future Cardiology · doi:10.2217/fca.14.55 · Cited by 19
Activation of the Proapoptotic Unfolded Protein Response in Plaques of the Human Carotid Artery
Dorweiler, B., Grechowa, I., Wallrath, A., Vahl, C., & Horke, S. (2014) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2014.06.038 · Cited by 19
Xu, W., Yu, H., Li, W., Gao, W. D., Guo, L., & Wang, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149062 · Cited by 19
“Subjects The 640 patients with chest pain for suspicious CAD who underwent coronary angiography or percutaneous coronary intervention (PCI) for the first time from Jan 2008 to Jun 2009 in Peking University Third Hospital were screened in series.”
BackgroundInfluentialHally, K. E., Flamme, A. C. L., Larsen, P., & Harding, S. A. (2016) · Thrombosis Research · doi:10.1016/j.thromres.2016.10.026 · Cited by 19
Qi, Z., Zhou, L., Dai, S., Zhang, P., Zhong, H., Zhou, W., Zhao, X., Xu, H., Zhao, G., Wu, H., et al. (2025) · Life Metabolism · doi:10.1093/lifemeta/loaf002 · Cited by 18
“This lack of understanding of platelet hyperactivation is particularly concerning given the rise in morbidity from coronary artery disease (CAD), despite declining mortality rates [6].”
Tanisawa, H., Matsumoto, H., Cadet, S. J., Higuchi, S., Ohya, H., Isodono, K., Irie, D., Kaneko, K., Sumida, A., Hirano, T., et al. (2023) · Radiology Cardiothoracic Imaging · doi:10.1148/ryct.230090 · Cited by 18
Evaluation of Serum Cysteine-Rich Protein 61 levels in Patients with Coronary Artery Disease
Deng, J., Qian, X., Li, J., Li, Y., Li, Y., & Luo, Y. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0390 · Cited by 18
Effects of hydrogen as adjuvant treatment for unstable angina
Si, Y., Tian, H., Dong, B., Zhang, Y., Wen, Y., Jia, X., Li, Y., Zhang, A., & Qin, S. (2021) · Experimental Biology and Medicine · doi:10.1177/15353702211009138 · Cited by 18
Cornelissen, A., Fuller, D. T., Fernandez, R., Zhao, X., Kutys, R., Binns-Roemer, E. A., Delsante, M., Sakamoto, A., Paek, K. H., Sato, Y., et al. (2021) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.315788 · Cited by 18
Self-citationSekimoto, T., Mori, H., Koba, S., Arai, T., Matsukawa, N., Sakai, R., Yokota, Y., Sato, S., Tanaka, H., Masaki, R., et al. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.07.008 · Cited by 18
Cope, F. O., Abbruzzese, B. C., Sanders, J., Metz, W., Sturms, K., Ralph, D. A., Blue, M., Zhang, J., Bracci, P. M., Bshara, W., et al. (2015) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2015.11.007 · Cited by 18
“appears to provide encouraging results with inter-disease consistency and reliability on the this immuno-biological strategy [43–139].”
BackgroundHiguma, T., Soeda, T., Yamada, M., Yokota, T., Yokoyama, H., Nishizaki, F., Xing, L., Yamamoto, E., Bryniarski, K. L., Dai, J., et al. (2016) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.116.003913 · Cited by 18
Dwivedi, G., Liu, Y., Tewari, S., Inácio, J. R., Pelletier‐Galarneau, M., & Chow, B. J. W. (2016) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000236 · Cited by 18
Lu, Y., Meng, X., Wang, L., & Wang, X. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.5573 · Cited by 18
“ACS represents a spectrum of diseases arising from coronary atherosclerotic plaque rupture, ranging from unstable angina (UA) to ST-segment elevated myocardial infarction (2,3).”
Gheorghe, A., Jacobsen, C., Thomsen, R., Línnet, K., Lynnerup, N., Andersen, C. B., Fuchs, A., Kofoed, K. F., & Banner, J. (2019) · International Journal of Legal Medicine · doi:10.1007/s00414-018-01998-8 · Cited by 18
Redfors, B., Chen, S., Ben‐Yehuda, O., Huang, X., Witzenbichler, B., Weisz, G., Liu, Y., Brodie, B. R., Rinaldi, M. J., Neumann, F., et al. (2019) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2019.07.044 · Cited by 18
Pepe, M., Carulli, E., Forleo, C., Moscarelli, M., Cillo, O. D., Bortone, A. S., Nestola, P. L., Biondi‐Zoccai, G., Giordano, A., & Favale, S. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa160 · Cited by 18
Imaging Coronary Artery Disease and the Myocardial Ischemic Cascade
Renker, M., Baumann, S., Rier, J. D., Ebersberger, U., Fuller, S. R., Batalis, N. I., Schoepf, U. J., & Chiaramida, S. A. (2015) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2014.11.010 · Cited by 18
Camaré, C., Vanucci‐Bacqué, C., Augè, N., Pucelle, M., Bernis, C., Swiader, A., Baltas, M., Bedos‐Belval, F., Salvayre, R., & Nègre‐Salvayre, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/9172741 · Cited by 19
“Early atherosclerotic lesions are characterized by clusters of lipidladen macrophagic cells that form the fatty streaks, whereas advanced atherosclerotic plaques are constituted by a central core containing extracellular lipids (mainly cholesterol) and cell debris, surrounded by macrophagic cells and a collagenous fib…”
BackgroundContribution of the arterial cells to atherosclerosis and plaque formation
Naiya, T., Meganathan, I., Ness, N. W., Oudit, G. Y., Murray, A. G., & Kassiri, Z. (2024) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00346.2024 · Cited by 17
Basic Mechanisms of Atherosclerosis
Bäck, M., & Hansson, G. K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-42880-4.00004-2 · Cited by 17
Chai, T., Tian, M., Yang, X., Qiu, Z., Lin, X., & Chen, L. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.874912 · Cited by 17
Zhang, X., Xiao, S., & Li, Q. (2018) · Journal of International Medical Research · doi:10.1177/0300060518787671 · Cited by 17
“Inflammatory cells, especially macrophages, are assumed to play critical roles in the initial stages and further progression of atherosclerotic inflammation.(2) Macrophages represent a heterogeneous cell population, with classically activated M1 (pro-inflammatory) macrophages and alternatively activated M2 (anti-infla…”
BackgroundAmbrose, J. A., & Bhullar, A. S. (2019) · European Medical Journal · doi:10.33590/emj/10314648 · Cited by 17
Hulten, E. A., Bittencourt, M. S., O’Leary, D. E., Shah, R. V., Ghoshhajra, B. B., Christman, M. P., Montana, P., Steigner, M. L., Truong, Q. A., Nasir, K., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1431 · Cited by 17
“Family history 595 (53) 276 (57) 103 (56) 170 (46) 46 (55) 0.”
BackgroundNeutrophils in Acute Coronary Syndrome
Kurup, R., & Patel, S. (2017) · EMJ Cardiology · doi:10.33590/emjcardiol/10314937 · Cited by 17
Unique Presentations and Etiologies of Myocardial Infarction in Women
Tweet, M. S., Best, P. J. M., & Hayes, S. N. (2017) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-017-0571-1 · Cited by 16
On-Demand Drug Delivery: Recent Advances in Cardiovascular Applications
Genç, H., Efthimiadou, E. Κ., & Cicha, I. (2022) · Frontiers in Drug Delivery · doi:10.3389/fddev.2022.913225 · Cited by 16
Wang, L., Zhai, P.-Q., Xue, L., Shi, C., Zhang, Q., & Zhang, H. (2023) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2023.107209 · Cited by 16
Savvopoulos, F., Keeling, M. C., Carassiti, D., Fogell, N. A., Patel, M., Naser, J., Gavara, N., de Silva, R., & Krams, R. (2024) · Journal of The Royal Society Interface · doi:10.1098/rsif.2023.0674 · Cited by 16
“First, histopathological studies have demonstrated the marked heterogeneity of plaque tissue with soft (lipid) and stiff (collagen, calcium) components in ruptured coronary plaques being situated a few microns apart [3,4].”
BackgroundTranslational molecular imaging: Thrombosis imaging with positron emission tomography
Balmforth, C., Whittington, B., Tzolos, E., Bing, R., Williams, M. C., Clark, L., Corral, C. A., Tavares, A., Dweck, M. R., & Newby, D. E. (2024) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2024.101848 · Cited by 16
Nanomaterials: Promising Tools for the Diagnosis and Treatment of Myocardial Infarction
Ge, Y., Wu, L., Mei, S., & Wu, J. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s500146 · Cited by 16
Andersen, M. H., Jensen, J. M., Kanstrup, H., Sand, N. P. R., Busk, M., Hansen, M. K., Thrane, P. G., Olesen, K. K. W., Nordestgaard, B. G., Blaha, M. J., et al. (2025) · European Heart Journal · doi:10.1093/eurheartj/ehaf497 · Cited by 16
Takahashi, N., Dohi, T., Endo, H., Takeuchi, M., Doi, S., Kato, Y., Okai, I., Iwata, H., Okazaki, S., Isoda, K., et al. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100747 · Cited by 16
Coronary Computed Tomography Angiography: Beyond Obstructive Coronary Artery Disease
Tonet, E., Boccadoro, A., Micillo, M., Cocco, M., Cossu, A., Pompei, G., Giganti, M., & Campo, G. C. (2023) · Life · doi:10.3390/life13051086 · Cited by 16
Ann, S. H., Jin, C. D., Singh, G. B., Lim, K. H., Chung, J.-W., Garg, S., Kim, M. H., Lee, W. S., Cho, K. I., Kim, S., et al. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0806-1 · Cited by 16
Sakaguchi, M., Ehara, S., Hasegawa, T., Matsumoto, K., Nishimura, S., Yoshikawa, J., & Shimada, K. (2016) · Heart and Vessels · doi:10.1007/s00380-016-0862-6 · Cited by 16
Nishihira, K., Shibata, Y., Yamashita, A., Kuriyama, N., & Asada, Y. (2017) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2017.12.001 · Cited by 16
Wu, T., Tan, M., Gong, H.-Y., Wang, Y., & Shuai, X. (2018) · Chinese Journal of Polymer Science · doi:10.1007/s10118-018-2158-z · Cited by 16
Oxidized Low‐Density Lipoprotein Induces Macrophage Production of Prothrombotic Microparticles
Marchini, J. F. M., Manica, A., Crestani, P., Dutzmann, J., Folco, E. J. E., Weber, H., Libby, P., & Croce, K. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.015878 · Cited by 16
Kılıçkesmez, K., Dall’Ara, G., Rama-Merchán, J. C., Ghione, M., Mattesini, A., Vinues, C. M., Konstantinidis, N. V., Pighi, M., Estévez‐Loureiro, R., Zivelonghi, C., et al. (2014) · IJC Heart & Vessels · doi:10.1016/j.ijchv.2014.03.003 · Cited by 16
Hougaard, M., Hansen, H. S., Thayssen, P., Antonsen, L., & Jensen, L. O. (2017) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2017.03.019 · Cited by 16
Myocardial Infarction: Risk Factors, Pathophysiology, Classification, Assessment and Management
Hegazy, A. A. (2022) · Cardiology Research and Reports · doi:10.31579/2692-9759/056 · Cited by 15
Nishi, T., Kume, T., Saito, Y., Kato, K., Tateishi, K., Yamada, R., Kitahara, H., Neishi, Y., Kobayashi, Y., & Uemura, S. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae460 · Cited by 15
Role of interleukins in the pathogenesis of coronary heart disease: A literature review
Rafaqat, S., Azam, A., Hafeez, R., Faseeh, H., Tariq, M., Asif, M. K., Arshad, A., & Noshair, I. (2025) · World Journal of Cardiology · doi:10.4330/wjc.v17.i3.103947 · Cited by 15
“The incidence of CAD has been growing continuously despite improvements in therapy that have reduced the death rates from CAD[1,2].”
Mills, N. L., Newby, L. K., Zaman, S., Almahmeed, W. A., Bucciarelli‐Ducci, C., Colvin, M. M., Dangas, G., DeVon, H. A., Dharmakumar, R., Gaziano, T. A., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001477 · Cited by 16
Relation of Low-Density Lipoprotein Cholesterol Level to Plaque Rupture
Kurihara, O., Kim, H. O., Russo, M., Araki, M., Nakajima, A., Lee, H., Takano, M., Mizuno, K., & Jang, I. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.08.016 · Cited by 15
(DGK), D. G. F. K. –. H. U. K. E. V., Schulze‐Bahr, E., (DGPK), D. G. F. P. K. U. A. H. E. V., (GfH), D. G. F. H. E. V., (DGRM), D. G. F. R. E. V., (DGP), D. G. F. P. E. V., Dettmeyer, R. B., Klingel, K., Kauferstein, S., Wolf, C. M., et al. (2021) · Der Kardiologe · doi:10.1007/s12181-020-00438-5 · Cited by 15
Aydınyılmaz, F., Özbeyaz, N. B., Gulıyev, İ., Algül, E., Şahan, H. F., & Kalkan, K. (2023) · Angiology · doi:10.1177/00033197231185204 · Cited by 15
“15 Dyslipidemia is among the most important components of this chain of events and has an essential role in the progression of coronary atherosclerosis.”
Atar, D., Bode, C., Stuerzenbecher, A., & Verheugt, F. W. A. (2014) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12063 · Cited by 15
Poulsen, C. B., Mortensen, M. B., Koechling, W., Sørensen, C. B., & Bentzon, J. F. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002800 · Cited by 15
Self-citationHung, C., Li, S., & Chung, W. (2018) · Respirology · doi:10.1111/resp.13298 · Cited by 15
Chen, L., Zheng, J., Xue, Q., & Zhao, Y. (2019) · Heart and Vessels · doi:10.1007/s00380-019-01434-w · Cited by 15
Liu, L., Li, Q., Yin, J., Zhao, Z., Sun, L., Ran, Q., Du, X., Wang, Y., Li, Y., Yang, Q., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.669730 · Cited by 15
“Vulnerable plaque in AS was characterized by thin fibrous cap that is infiltrated by inflammatory cells and low VSMC density (Falk et al., 2013) (Koga and Aikawa, 2012) reported that macrophage may promote the activation and pro-atherogenic functions of SMC.”
BackgroundCrombag, G. A. J. C., Aizaz, M., Schreuder, F. H. B. M., Benali, F., van Dam-Nolen, D. H. K., Liem, M. I., Lucci, C., van der Steen, A. F. W., Daemen, M. J. A. P., Mess, W. H., et al. (2022) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7384 · Cited by 15
Exploring unknowns in cardiology
Alfieri, O., Mayosi, B. M., Park, S., Sarrafzadegan, N., & Virmani, R. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2014.123 · Cited by 15
Self-citationHaynes, A., Linden, M. D., Robey, E., Naylor, L. H., Ainslie, P. N., Cox, K. L., Lautenschlager, N. T., & GREEN, D. J. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00079.2018 · Cited by 15
“However, in the 467 event of physiological agonist exposure typical of that which occurs following plaque 468 disruption initiating acute coronary events (10), exercise training may not alter the 469 thrombogenic response or alter susceptibility to the consequences of agonist470 induced platelet activation.”
BackgroundThe protective effects of uric acid against myocardial ischemia via the Nrf2 pathway
Ma, P., Zhao, M., Li, Y., Zhang, G., Ma, Y., Shi, Y., Su, P., Chen, R., Tang, Z., Zhang, Y., et al. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176062 · Cited by 14
Zhu, G., Gao, H., Li, Y., Li, X., Yang, X., Wang, C., Guo, Z., Fan, H., & Fan, L. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154969 · Cited by 14
Precht, H., Kitslaar, P. H., Broersen, A., Dijkstra, J., Gerke, O., Thygesen, J., Egstrup, K., & Lambrechtsen, J. (2016) · Journal of cardiovascular computed tomography · doi:10.1016/j.jcct.2016.09.006 · Cited by 14
Yamanaka, Y., Shimada, Y., Tonomura, D., Terashita, K., Suzuki, T., Yano, K., Nishiura, S., Yoshida, M., Tsuchida, T., & Fukumoto, H. (2021) · Journal of Interventional Cardiology · doi:10.1155/2021/5590109 · Cited by 14
“Previous studies have reported that the exposed necrotic core of ruptured plaque is highly thrombogenic and contains larger amounts of red thrombus compared with other plaque phenotypes [21, 22].”
BackgroundCorredor-Orlandelli, D., Sambracos-Parrado, S., Mantilla-García, S., Tovar-Tirado, J., Vega-Ramírez, V., Mendoza-Ayús, S. D., Peña, L. C., Leal, M. F., Rodríguez-Carrillo, J., León-Torres, J., et al. (2021) · Vascular Health and Risk Management · doi:10.2147/vhrm.s330766 · Cited by 14
He, Y., Liu, X., Zhang, J., & Peng, C. (2023) · Biosensors · doi:10.3390/bios13110971 · Cited by 14
“When atherosclerotic plaques rupture within the coronary arteries, this becomes the primary trigger of coronary artery disease, a condition that can lead to severe complications such as acute coronary syndrome and sudden cardiac death [1,2].”
BackgroundCyanidin prevents cardiomyocyte apoptosis in mice after myocardial infarction
Gang, D., Ouyang, Q., Yang, Y., Masood, M., Wang, Y., Linhui, J., Su, H., Li, G., Liu, C., Nasser, M. I., et al. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-02975-2 · Cited by 14
“Because persistent ventricular remodeling is a major cause of MI heart failure, avoiding ventricular remodeling is critical for preventing cardiac function decline (Falk et al. 2013; Hausenloy et al. 2019).”
Correlation between SHP-1 and carotid plaque vulnerability in humans
Huang, Y., Zhu, L., Tan, J., Guo, W., Zhou, Y., Shi, W., & Yu, B. (2020) · Cardiovascular Pathology · doi:10.1016/j.carpath.2020.107258 · Cited by 14
Zhang, R., Ji, Z., Yao, Y., Zuo, W., Yang, M., Qu, Y., Su, Y., Ma, G., & Li, Y. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118517 · Cited by 14
Mangiacapra, F., Viscusi, M. M., Paolucci, L., Nusca, A., Melfi, R., Ussia, G. P., & Grigioni, F. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.781485 · Cited by 14
Bilolikar, A., Goldstein, J. A., Madder, R. D., & Chinnaiyan, K. M. (2015) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev281 · Cited by 14
Haynes, A., Linden, M. D., Robey, E., Naylor, L. H., Cox, K. L., Lautenschlager, N. T., & GREEN, D. J. (2017) · Physiological Reports · doi:10.14814/phy2.13189 · Cited by 14
“Thrombosis is an integral component of acute coronary syndromes such as acute myocardial infarction (MI) and ischemic stroke (Falk et al. 2013; Libby 2013).”
InfluentialCT Imaging of the Vulnerable Plaque
Small, G. R., & Chow, B. J. W. (2017) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-017-0592-9 · Cited by 14
Metadata
- Authors
- Falk, E., Nakano, M., Bentzon, J. F., Finn, A. V., & Virmani, R.
- Affiliations
- Aarhus University Hospital (DK)
- CVPath Institute (US)
- Emory University Hospital (US)
- Corresponding author
- Virmani, Renu
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-12-13
- Volume
- 34
- Issue
- 10
- Pages
- 719-728
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2115593266
- Cited by
- 1,047
- References
- 161
- Citations by year
- 2026: 53 · 2025: 55 · 2024: 52 · 2023: 81 · 2022: 68 · 2021: 105 · 2020: 81 · 2019: 83 · 2018: 79 · 2017: 106 · 2016: 76 · 2015: 99 · 2014: 74 · 2013: 32 · 2012: 1
- FWCI
- 6.07
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Heart Journal (publishedVersion)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Coronary Interventions and Diagnostics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Keywords
- acute coronary syndrome, plaque rupture, plaque erosion, intraplaque hemorrhage, acute myocardial infarction, unstable angina, coronary plaque morphology, necrotic core, macrophages, M1/M2 macrophages, sudden cardiac death, coronary artery disease
- MeSH terms
- Chronic Disease, Coronary Artery Disease, Coronary Thrombosis, Female, Fibrin, Hemorrhage, Humans, Macrophages, Male, Necrosis, Platelet Aggregation, Risk Factors, Rupture, Spontaneous, Acute Coronary Syndrome, Cardiac Imaging Techniques, Plaque, Atherosclerotic, Vascular Calcification
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.